Skip to main content

Table 3 Association between early thromboprophylaxis and mortality by admission diagnosis

From: Mortality data from omission of early thromboprophylaxis in critically ill patients highlights the importance of an individualised diagnosis-related approach

Characteristic

Odds ratios (95% CI)

P-value

Overall

  

Thromboprophylaxis status

  

 Yes

Ref

 

 No

1.35 (1.31–1.40)

< 0.001

 Contraindicated

1.35 (1.31–1.40)

< 0.001

 Not indicated

1.22 (0.94–1.12)

0.522

Admission diagnosis

  

Head trauma (with or without multi trauma) (n = 15,618)

  

 Yes

Ref

 

 No

1.23 (0.97–1.56)

0.090

 Contraindicated

1.20 (0.95–1.51)

0.115

 Not indicated

1.71 (1.08–2.69)

0.020

Cardiac arrest (n = 29,498)

  

 VTE prophylaxis

  

 Yes

Ref

 

 No

1.85 (1.65–2.07)

< 0.001

 Contraindicated

1.37 (1.16–1.62)

< 0.001

 Not indicated

1.29 (1.91–2.75)

< 0.001

Intracerebral haemorrhage (n = 7,448)

  

 Yes

Ref

 

 No

1.48 (1.19–1.84)

< 0.001

 Contraindicated

1.14 (0.96–1.37)

0.136

 Not indicated

2.41 (1.52–3.82)

< 0.001

Subarachnoid haemorrhage (n = 6,598)

  

 Yes

Ref

 

 No

1.09 (0.79–1.50)

0.582

 Contraindicated

0.97 (0.74–1.26)

0.824

 Not indicated

1.38 (0.73–2.59)

0.316

Stroke (n = 11,615)

  

 Yes

Ref

 

 No

1.26 (1.05–1.52)

0.014

 Contraindicated

1.07 (0.90–1.27)

0.457

 Not indicated

1.16 (0.82–1.63)

0.392

  1. Adjusted for Australian and New Zealand Risk of Death (ANZROD). ANZROD is derived from patient and clinical characteristics, including the Acute Physiology and Chronic Health Evaluation (APACHE) III, ICU admission source, admission diagnoses, Acute Physiology score (APS), APACHE III chronic health score, treatment limitation, and ventilation status. VTE-Venous thromboembolism